Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Vertex Pharmaceuticals reported $1.04B in EBIT for its fiscal quarter ending in September of 2023.

Ebit Change Date
AbbVie USD 2.41B 2.49B Sep/2023
Acadia Pharmaceuticals USD -57776000 60.81M Sep/2023
Agios Pharmaceuticals USD -100897000 7.2M Sep/2023
Alnylam Pharmaceuticals USD 213.87M 443.7M Sep/2023
Amgen USD 2.05B 701M Sep/2023
Arrowhead Research USD -108330000 5.63M Sep/2023
Biogen USD 285.3M 392.9M Sep/2023
BioMarin Pharmaceutical USD 25.66M 33.21M Sep/2023
Bluebird Bio USD -84729000 568K Sep/2023
Bristol-Myers Squibb USD 2.72B 194M Sep/2023
Gilead Sciences USD 2.62B 958M Sep/2023
Incyte USD 215.33M 13.73M Sep/2023
Insmed USD -138671000 83.36M Sep/2023
Ionis Pharmaceuticals USD -143265000 53.07M Sep/2023
J&J USD 5.71B 1.47B Sep/2023
Merck USD 6.52B 10.93B Sep/2023
Moderna USD -2012000000 145M Sep/2023
Neurocrine Biosciences USD 141.2M 67.6M Sep/2023
Pfizer USD -3149000000 5.27B Sep/2023
PTC Therapeutics USD -118164000 126.42M Sep/2023
Regeneron Pharmaceuticals USD 1.21B 194.5M Sep/2023
Roche Holding CHF 10.6B 2.12B Jun/2023
Sarepta Therapeutics USD -20842000 112.68M Sep/2023
Ultragenyx Pharmaceutical USD -145097000 2.86M Sep/2023
United Therapeutics USD 327M 10M Sep/2023
Vertex Pharmaceuticals USD 1.04B 11.7M Sep/2023